Double Anaerobic Threshold in Athletes

March 2, 2023 updated by: Centro Cardiologico Monzino

Evaluation of the Presence of a Double Anaerobic Threshold in a Population of Athletes

During an incremental cardiopulmonary exercise test (CPET) performed with a ramp protocol, it is very important to determine the anaerobic threshold, defined as the point at which the metabolism switches from being predominantly aerobic to also being anaerobic. The anaerobic threshold can be determined invasively, by identifying the increase in blood lactates with an arterial sampling, or, more commonly, non-invasively by three methods: the V-slope method, the ventilatory equivalents method and by using end-expiratory oxygen and carbon dioxide pressure (PETO2 and PETCO2 respectively). Normally, the anaerobic threshold is determined by the first method and the other two are used to confirm the value. The finding of different anaerobic threshold values using these three methods has been reported anecdotally in the past, while a prevalence of 11% in a healthy population has recently been described. Regular training, particularly that aimed at endurance sports, is able to shift the anaerobic threshold to higher exercise intensities. At present, the physiological reasons for the presence of a double threshold are unclear.

The aim of the study is to identify the anaerobic threshold by means of the V-slope method and by means of the ventilatory equivalents method in athletes who have performed an incremental ramp CPET at the laboratories of the investigating centres, to assess in how many athletes a double threshold is present and to try to interpret the physiological/ pathophysiological significance of this finding.

In this retrospective and prospective observational study, healthy male and female athletes who have had a cardiopulmonary test at our laboratories from 2007 to the present (retrospectively recruited) and prospectively recruited until the calculated sample size is reached will be enrolled.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Florence, Italy
        • Recruiting
        • Azienda Ospedaliero-Universitaria Careggi
        • Contact:
          • Pietro Amedeo Modesti, Prof
      • Foggia, Italy
        • Not yet recruiting
        • University of Foggia
        • Contact:
          • Michele Correale, MD
      • Milan, Italy, 20138

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Healthy male and female athletes who performed a cardiopulmonary test at our laboratories from 2007 to the present (retrospectively recruited) and prospectively recruited will be enrolled

Description

Inclusion Criteria:

  • no major present or past illnesses, no ongoing treatment
  • At least 2 training sessions per week.

Exclusion Criteria:

  • Current illnesses and treatments for any physical condition that could potentially alter performance
  • Subjects who have performed a submaximal test (RER < 1.05)
  • CPET during which the AT determination is poorly assessable, i.e. due to changes in respiration.
  • obese subjects (BMI >30)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Athletes groups
Time Frame: immediately after the incremental cardiopulmonary exercise test evaluation
Identification of two groups of athletes (those with identified double anaerobic threshold and those without)
immediately after the incremental cardiopulmonary exercise test evaluation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Groups differences in age
Time Frame: immediately after the incremental cardiopulmonary exercise test evaluation
Assess whether there are differences in age (years) between the two groups of subjects.
immediately after the incremental cardiopulmonary exercise test evaluation
Groups differences in sport practised
Time Frame: immediately after the incremental cardiopulmonary exercise test evaluation
Assess whether the two groups of subjects differ in term of the sport practised (information collected during patient interview)
immediately after the incremental cardiopulmonary exercise test evaluation
Groups differences in exercise performance
Time Frame: immediately after the incremental cardiopulmonary exercise test evaluation
Assess whether the two groups of subjects differ in term of exercise performance (peak power (Watts) reached during CPET)
immediately after the incremental cardiopulmonary exercise test evaluation
Groups differences in VO2
Time Frame: immediately after the incremental cardiopulmonary exercise test evaluation
Assess whether there are differences in the oxygen intake VO2 (cardiopulmonary exercise test) between the two groups
immediately after the incremental cardiopulmonary exercise test evaluation
Groups differences in VE/VCO2 slope
Time Frame: immediately after the incremental cardiopulmonary exercise test evaluation
Assess whether there are differences in minute ventilation/carbon dioxide production relationship VE/VCO2 slope (cardiopulmonary exercise test) between the two groups
immediately after the incremental cardiopulmonary exercise test evaluation
Groups differences in VE
Time Frame: immediately after the incremental cardiopulmonary exercise test evaluation
Assess whether there are differences in minute ventilation VE (cardiopulmonary exercise test) between the two groups
immediately after the incremental cardiopulmonary exercise test evaluation
Differences in VO2 at the two thresholds
Time Frame: immediately after the incremental cardiopulmonary exercise test evaluation
Highlight the differences in oxygen intake VO2 (cardiopulmonary exercise test), in the subjects with double anaerobic threshold, at the two thresholds.
immediately after the incremental cardiopulmonary exercise test evaluation
Differences in VE/VCO2 at the two thresholds
Time Frame: immediately after the incremental cardiopulmonary exercise test evaluation
Highlight the differences in minute ventilation/carbon dioxide production relationship VE/VCO2 slope (cardiopulmonary exercise test), in the subjects with double anaerobic threshold, at the two thresholds.
immediately after the incremental cardiopulmonary exercise test evaluation
Differences in VE at the two thresholds
Time Frame: immediately after the incremental cardiopulmonary exercise test evaluation
Highlight the differences in minute ventilation VE (cardiopulmonary exercise test), in the subjects with double anaerobic threshold, at the two thresholds.
immediately after the incremental cardiopulmonary exercise test evaluation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Piergiuseppe Agostoni, Prof., Centro Cardiologico Monzino

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2022

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

February 21, 2023

First Submitted That Met QC Criteria

March 2, 2023

First Posted (Actual)

March 15, 2023

Study Record Updates

Last Update Posted (Actual)

March 15, 2023

Last Update Submitted That Met QC Criteria

March 2, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • CCM 1719

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Athlete

3
Subscribe